An emerging tool for assessing the impact of T2DM on immune aging in PLWH is the triglyceride–glucose (TyG) index, a surrogate marker of insulin resistance associated with reduced CD4/CD8 ratio, increased frequencies of senescent CD8+ T cells, and greater clinical frailty [32,46,47]. This evidence concerns the gene CD8A and type 2 diabetes mellitus.